
IREDA Q2 Results FY26: Q2 PAT Rises 41.49% to ₹549 Crore; Revenue Up 26.19% YoY
Posted by : sachet | Wed Oct 15 2025

Click and Sign Up to Get Live Updates on Q2 Results
IREDA Q2 Results FY26: IREDA posted its Q2 results on 10th October 2025. The company posted robust numbers, with Q2 PAT standing at ₹549 crores against revenue of ₹2,057 crores. During Q2 FY26, the profit increase of the company was recorded at 41.49% YoY, and the revenue increased 26.19% YoY.
IREDA Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹2,057 | ₹1,630 |
| Profit Before Tax (PBT) | ₹696 | ₹460 |
| Profit After Tax (PAT) | ₹549 | ₹388 |
(Figures in crores)
IREDA Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- IREDA clocked Q2 FY26 standalone revenue of ₹2,057 crores vs ₹1,630 crores.
- On the profit front, IREDA earned a standalone PAT of ₹549 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹388 crore.
- As per the standalone figures, the quarterly PAT of IREDA has increased by 41.49%, and revenue has increased by 26.19% YoY.
IREDA Share Price Performance
On the opening bell of 14th October 2025, the shares of IREDA opened at ₹150.68 per share. However, the initial gains have surged out as of now, and IREDA shares are trading at ₹154.50 per share, higher than their opening price.
Considering the long-term performance, IREDA shares have yielded close to -30.25% returns in the past 1 year, and 5-year returns stand at 146.22%. Over the maximum timeframe, the IREDA share provided 146.22% returns to investors.
What Analysts Expect Post Q2 Results?
As IREDA has posted robust Q2 results for FY26, analysts are expecting positive trends in its share price. As per the analysts, IREDA ‘s share price could reach ₹190.20 per share in the coming year, and in downtrends, the share price could hit the level of ₹120.60 per share. However, one must ignore the risk of volatility in the stock market and invest in IREDA ‘s shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Taurian MPS IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Accelerator IPO GMP & Review: Apply or Avoid?
Related Posts
Bayer CropScience Q2 Results 2025 Highlights: Net Profit Rises by 12.03% & Revenue Down 10.63% YoY
Aadhar Housing Finance Q2 Results 2025 Highlights: Net Profit Rises by 17.12% & Revenue Up 17.38% YoY
Emmvee Photovoltaic IPO GMP: Day 1 IPO Live Updates
Shreeji Global FMCG IPO Listing Preview: What to Expect Now?
Mahamaya Lifesciences IPO GMP: Day 1 IPO Live Updates

